266 related articles for article (PubMed ID: 15312098)
1. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Drozdzik M; Mysliwiec K; Lewinska-Chelstowska M; Banach J; Drozdzik A; Grabarek J
J Clin Periodontol; 2004 Sep; 31(9):758-63. PubMed ID: 15312098
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Drozdzik M; Kurzawski M; Drozdzik A; Kotrych K; Banach J; Pawlik A
J Clin Periodontol; 2005 Sep; 32(9):955-8. PubMed ID: 16104959
[TBL] [Abstract][Full Text] [Related]
3. Role of MDR1 gene polymorphisms in gingival overgrowth induced by cyclosporine in transplant patients.
De Iudicibus S; Castronovo G; Gigante A; Stocco G; Decorti G; Di Lenarda R; Bartoli F
J Periodontal Res; 2008 Dec; 43(6):665-72. PubMed ID: 18702631
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-3 gene polymorphism in renal transplant patients with gingival overgrowth.
Drozdzik A; Kurzawski M; Lener A; Kozak M; Banach J; Drozdzik M
J Periodontal Res; 2010 Feb; 45(1):143-7. PubMed ID: 19778329
[TBL] [Abstract][Full Text] [Related]
5. SPARC gene polymorphism in renal transplant patients with gingival overgrowth.
Drozdzik A; Kurzawski M; Kozak M; Banach J; Drozdzik M
J Periodontol; 2007 Nov; 78(11):2185-9. PubMed ID: 17970686
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-1 gene polymorphism in renal transplant patients with and without gingival enlargement.
Kurzawski M; Drozdzik A; Dembowska E; Pawlik A; Banach J; Drozdzik M
J Periodontol; 2006 Sep; 77(9):1498-502. PubMed ID: 16945025
[TBL] [Abstract][Full Text] [Related]
7. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Kozak M; Kurzawski M; Wajda A; Lapczuk J; Lipski M; Dziewanowski K; Drozdzik M
Oral Dis; 2011 May; 17(4):414-9. PubMed ID: 21306480
[TBL] [Abstract][Full Text] [Related]
9. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
[TBL] [Abstract][Full Text] [Related]
10. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
[TBL] [Abstract][Full Text] [Related]
11. Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (-174 G/C) gene polymorphism.
Cota LO; Viana MB; Moreira PR; Gomez RS; Cortelli JR; Cortelli SC; Costa FO
Arch Oral Biol; 2010 Jul; 55(7):494-501. PubMed ID: 20430366
[TBL] [Abstract][Full Text] [Related]
12. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
[TBL] [Abstract][Full Text] [Related]
13. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
15. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
Schwab M; Schaeffeler E; Marx C; Fromm MF; Kaskas B; Metzler J; Stange E; Herfarth H; Schoelmerich J; Gregor M; Walker S; Cascorbi I; Roots I; Brinkmann U; Zanger UM; Eichelbaum M
Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
[TBL] [Abstract][Full Text] [Related]
16. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
[TBL] [Abstract][Full Text] [Related]
17. Relationship between IL-1A polymorphisms and gingival overgrowth in renal transplant recipients receiving Cyclosporin A.
Bostanci N; Ilgenli T; Pirhan DC; Clarke FM; Marcenes W; Atilla G; Hughes FJ; McKay IJ
J Clin Periodontol; 2006 Nov; 33(11):771-8. PubMed ID: 16965524
[TBL] [Abstract][Full Text] [Related]
18. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
[TBL] [Abstract][Full Text] [Related]
19. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
Li D; Gui R; Li J; Huang Z; Nie X
Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
